April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Bruch’s Membrane Changes in a Transgenic Mice Model of Alzheimer’s Disease
Author Affiliations & Notes
  • Imre Lengyel
    Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, United Kingdom
  • Ashraf Gango
    Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, United Kingdom
  • Neda Barzegar-Befroei
    Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, United Kingdom
  • Sabrina Cahyadi
    Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, United Kingdom
  • Zhi-Hong Chi
    Key Laboratory of Medical Cell Biology of Ministry of Education, China Medical University, Shenyang, China
  • Zhan-You Wang
    Key Laboratory of Medical Cell Biology of Ministry of Education, China Medical University, Shenyang, China
  • Tunde Peto
    Research & Development, Moorfields Eye Hospital, London, United Kingdom
  • Footnotes
    Commercial Relationships  Imre Lengyel, None; Ashraf Gango, None; Neda Barzegar-Befroei, None; Sabrina Cahyadi, None; Zhi-Hong Chi, None; Zhan-You Wang, None; Tunde Peto, None
  • Footnotes
    Support  We thank the Bill Brown Charitable Trust, Windayer Fundation, Mercer Fund, DHPA from MRC, The Henry Smith Charity, the Special Trustees of MEH and the Lowy Medical Foundation for support.
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 956. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Imre Lengyel, Ashraf Gango, Neda Barzegar-Befroei, Sabrina Cahyadi, Zhi-Hong Chi, Zhan-You Wang, Tunde Peto; Bruch’s Membrane Changes in a Transgenic Mice Model of Alzheimer’s Disease. Invest. Ophthalmol. Vis. Sci. 2011;52(14):956.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

Age-related macular degeneration (AMD) and Alzheimer’s disease (AD) share almost identical genetic and environmental risk factors and similar molecular processes. The purpose of this study was to examine whether deposit formation in the brain is associated with changes in protein and zinc deposition in Bruch’s membrane (BM) in a transgenic animal model for AD.

 
Methods:
 

APP/PS1 transgenic mice model of AD was used to study ultra structural changes of BM. BM thickness were measured at segments where the choriocapillary lumen was both open and lined by a single layer of endothelium, avoiding the intercapillary pillars, far periphery and optic nerve. Ten measurements were made in segments of equal length form 10 pictures from each mouse using Image J 1.43. Zinc in BM was detected using autometallography.

 
Results:
 

Our data confirms earlier reports showing a thickening of BM with normal ageing. At 4 month the average thickness of BM in wild type animals was 0.345 ± 0.047 µm that increased to 0.63 ± 0.12 µm by 12 months. However, in the transgenic groups BM was already thickened at 4 month (0.53 ± 0.04 µm). At 12 months there was a dramatic increase in BM thickenss (1.21 ± 0.07 µm) accompanied by the appearance of sub-RPE deposits. There was substantially more zinc in BM in transgenic animals compared to wild type. Injection of DEDTC (a zinc selective chelator) completely abolished autometallographic labelling of zinc.

 
Conclusions:
 

The APP/PS1 transgenic mice have a thickened Bruch’s membrane and sub-RPE deposits are clearly visible. This thickening is associated with increased zinc deposition. These might be relevant to understand how sub-RPE deposits are formed but also important in strengthening further the potential association between AMD and AD. Importantly, this transgenic model for AD may represent a model to study early deposit formation leading to retinal degeneration and blindness in AMD.

 
Keywords: age-related macular degeneration • Bruch's membrane • extracellular matrix 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×